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Abstract
Background: The ability of staphylococci to grow in a wide range of salt concentrations is well documented. In
this study, we aimed to clarify the role of cardiolipin (CL) in the adaptation of Staphylococcus aureus to high
salinity.
Results: Using an improved extraction method, the analysis of phospholipid composition suggested that CL levels
increased slightly toward stationary phase, but that this was not induced by high salinity. Deletion of the two
CL synthase genes, SA1155 (cls1) and SA1891 (cls2), abolished CL synthesis. The cls2 gene encoded the dominant
CL synthase. In a cls2 deletion mutant, Cls1 functioned under stress conditions, including high salinity. Using these
mutants, CL was shown to be unnecessary for growth in either basal or high-salt conditions, but it was critical for
prolonged survival in high-salt conditions and for generation of the L-form.
Conclusions: CL is not essential for S. aureus growth under conditions of high salinity, but is necessary for survival
under prolonged high-salt stress and for the generation of L-form variants.
Background
Staphylococcus aureus is an opportunistic pathogen that
causes a wide range of diseases in both immunologically
normal and compromised hosts. The natural habitat of S.
aureus is the nasal cavity of warm-blooded animals. Over
the past ~50 years, S. aureus has undergone genetic
changes that have resulted in antibiotic-resistant strains
[1,2]. Importantly, the methicillin-resistant strains (MRSA)
are now the most common cause of nosocomial S. aureus
infections and are spreading throughout communities [3].
Staphylococcus aureus has a number of characteristics
that allow it to survive host bactericidal factors and envir-
onmental stresses, including drastic changes in osmotic
pressure [4-6]. Osmoprotectants such as choline, glycine
betaine, and proline accumulate in cells in response to
osmotic stress [7-11]. Multiple genes, including the
branched-chain amino acid transporter gene brnQ [12]
and the arsenic operon regulatory gene arsR [13], coop-
eratively participate in salt tolerance. In addition, a very
large cell wall protein, Ebh, is involved in tolerance to
transient hyperosmotic pressure [14].
In general strategy, the phospholipid composition of
bacteria changes in response to growth phase or envir-
onmental stressors such as osmolality [15], pH [16,17],
temperature, and the presence of organic solvents
[18,19]. In the 1970s, the molecular mechanism of sta-
phylococcal salt resistance was studied, focusing on a
phospholipid, cardiolipin (CL) [20]. CL possesses four
acyl groups and carries two negative charges [21]. In
stationary phase, 30% of the S. aureus cell membrane is
composed of CL [22]. It has been reported that CL can
stabilize liposomes during osmotic stress [23] and that it
is required for the growth of Escherichia coli and Bacil-
lus subtilis under high-salt conditions [24,25]. However,
the role of CL in the molecular mechanism of staphylo-
coccal resistance to high salinity remains unknown.
In this study, we used an improved lipid extraction
method to assess the phospholipid composition of
S. aureus and performed molecular genetic analyses to
evaluate the role of CL in the resistance of S. aureus to
high salinity.
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Staphylococcus aureus phospholipid composition
The phospholipid composition of S. aureus grown under
various conditions was analyzed. Previous studies with
specific S. aureus strains under defined conditions have
indicated that the CL level increases as the cells enter
stationary phase [22] and when cultured under high-salt
conditions [20]. In our initial experiments, the CL level
varied among the S. aureus strains tested (Additional
file1, Figure S1), probably because the cell wall reduced
the CL extraction efficiency. Pretreatment with lysosta-
phin (0.1 mg ml
-1 for 3 min at 37°C), which degrades
the Gly5-bridge structures in cell walls [26,27], increased
the CL extraction efficiency without affecting the
amounts of other phospholipids extracted (Figure 1).
With this method, the CL level did not differ signifi-
cantly among the strains tested (N315, NKSBm, NKSBv,
MRSA No. 7, MRSA No. 33, and COL; Additional file1,
Figure S1). Therefore, cells were treated with lysostaphin
prior to lipid extraction in all subsequent experiments.
The phospholipid profile obtained in the present study
(Figure 2) was similar to those reported by others
[22,28]. The signal that intensified as cells entered sta-
tionary phase (Figs. 2 and 8) was identified as CL based
on molecular mass analysis [28]. However, we did not
detect a reproducible increase in the CL level in
response to the addition of NaCl (Figure 2). This was
the case for S. aureus N315 (Figure 2) and strain 8325-4
and its derivatives RN4220 and SH1000 (data not
shown).
Molecular genetic analysis of two cardiolipin synthase
homologs
Figure 3 shows the phospholipid synthesis pathway,
modified from a diagram in the KEGG pathway database
[29]. A database search identified two S. aureus genes,
CL
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Figure 1 Effect of lysostaphin treatment on CL extraction efficiency. Prior to lipid extraction, cells (N315) were incubated for 3 min at 37°C
in the presence of lysostaphin at the indicated concentrations. CL: Cardiolipin. PG: Phosphatidylglycerol. LPG: Lysyl-phosphatidylglycerol. The
means and standard deviations of relative signal intensities are shown at the bottom.
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Page 2 of 12SA1155 and SA1891, as homologs of B. subtilis clsA (CL
synthase gene; one of three paralogous genes, clsA, ywjE,
and ywiE) [24,30]. We constructed single and double
mutants of SA1155 and SA1891 genes in S. aureus
N315. No decrease in the CL level was observed in the
SA1155 mutant (Ncls1; Figure 4). In the SA1891 mutant
(Ncls2), the CL level decreased, but not completely. In
the double mutant (Ncls1/cls2), the CL signal was unde-
tectable, and the phosphatidylglycerol (PG) signal was
increased. This is consistent with the CL synthesis path-
way. An identical result was observed in the mutants
derived from S. aureus RN4220, 8325-4, SH1000, and
MT01 (data not shown). These data strongly suggest
that both SA1155 and SA1891 are CL synthase genes,
and thus we refer to them as cls1 and cls2, respectively.
Importance of CL for long-term survival under high
salinity
Given that CL plays a regulatory role during cell replication
and division in E. coli [28,31,32], we investigated the role of
the cls genes in cells during growth phase transitions in 0.1%
NaCl LB (Figure 5). Mutation of the cls genes did not affect
the growth curve until 47 h (Figure 5A), after which the
cls1/cls2 double mutant showed slightly lower optical den-
sity. However, stationary-phase CFU numbers did not differ
significantly between the cls1/cls2 double mutant and the
parent strain (Figure 5B). Moreover, the CFU numbers were
sustained in both strains until at least 700 h post-inoculation
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Figure 2 Phospholipid composition of S. aureus N315 under
various growth conditions. Cells were grown in LB containing
either 0.1% or 15% NaCl, and harvested during the exponential
(exp.) or stationary phase. The means and standard deviations of
relative signal intensities are shown at the bottom.
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Figure 3 Lipid synthesis pathway in S. aureus (modified from
the KEGG pathway database). SA1155 (cls1) and SA1891 (cls2) are
homologs of the B. subtilis cls gene.
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Page 3 of 12(data not shown). We conclude that CL is not necessary for
cell growth and stationary phase survival of S. aureus under
these conditions.
In a high-salinity medium (15% NaCl LB), the growth
yield was reduced in N315 and cls mutants (Figure 6A),
but the growth of cls mutants was not significantly dif-
ferent from that of the parent strain. In contrast, the
number of cls1/cls2 double mutant CFUs was drastically
reduced after ~105 to 153 h in high-salinity medium
(Figure 6B). This reduction was not observed in either
of the single mutants, suggesting that one cls gene is
sufficient for long-term survival in high salinity. No
growth was detected in medium containing 25% NaCl.
Although the number of CFUs decreased gradually in
both N315 and its cls mutants, the decrease was much
faster for the cls1/cls2 double mutant after 46 h. Based
on these findings, we conclude that CL is critical for sta-
phylococcal fitness under conditions of high salinity.
No difference in susceptibility to antibiotics affecting
cell walls (vancomycin, teicoplanin, cefarotin, cefmeta-
zole, and cefazoline), quinolones (ofloxacin, norfloxacin,
ciprofloxacin, and nalidixic acid), arbekacin, or the anti-
microbial peptides ASABF-a [33] and nisin was
observed between the N315 and its cls mutants (data
not shown). The MIC of nisin for both S. aureus N315
and its cls mutants was 80 μgm l
-1.
Effect of cls mutations on L-form generation
Staphylococcus aureus cannot form normal colonies in
the presence of penicillin. After a prolonged incubation,
colonies with a ‘fried egg shape’ emerge [34]. This
adapted cell form is termed the L-form [35]. Staphylo-
coccus aureus has especially high turgor pressure, and
the L-form is induced under conditions of 5% NaCl and
5% sucrose. The L-form cell is able to grow without a
cell wall, is Gram-negative, and lyses readily under
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Figure 5 Growth and stationary-phase survival under low salinity. Cells were grown in 0.1% NaCl LB. A: Growth was monitored by optical density
(OD) measurements. N315: filled diamonds; cls1 mutant: filled squares; cls2 mutant: filled triangles; cls1/cls2 double mutant: open circles. Optical
densities were checked at least twice, and the means are shown. After 47 h, the OD of only N315 and its cls1/cls2 double mutant were measured. B:
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chromatography of phospholipids. Cells were harvested at 23 h. The phospholipid profile was confirmed to be similar up to 153 h (data not shown).
The means and standard deviations of relative signal intensities from two independent experiments are shown on the right.
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Page 5 of 12hypotonic conditions (e.g., water). Thus, the L-form cell
must have mechanisms allowing it to survive in such
environments without the physical support of a
cell wall. As one L-form strain has been shown to accu-
mulate large amounts of CL [36], we investigated the
possibility that CL is important in the generation of the
L-form variant by constructing cls mutants in the MT01
strain, which is capable of generating the L-form. The
lack of cls genes did not abolish L-form generation,
although the efficiency of L-form generation was
reduced in the cls2 single and cls1/cls2 double mutants,
but not in the cls1 single mutant (Figure 7).
Function of cls1 in stress responses
Figure 8 summarizes the CL accumulation in each strain
grown under 0.1 and 15% NaCl concentrations. The
total CL level did not differ detectably between the cls1
mutant and the parent strain grown in basal culture
medium, indicating that under these conditions Cls2 is
the dominant CL synthase. The cls2 mutant accumu-
lated CL under high salinity, but not under low salinity.
As the cls1/cls2 double mutant did not synthesize CL,
the synthesis of CL by the cls2 mutant under high sali-
nity must occur via Cls1. These synthesis profiles were
shared among the mutant derivatives of N315 (Figure
8), 8325-4, and SH1000 (data not shown), suggesting
that S. aureus Cls1 has a specific role under conditions
of high salinity. We also tested the induction of
Cls1-dependent CL accumulation in response to other
stressors. Extreme conditions such as low pH, high tem-
perature, or an anaerobic environment induced CL
accumulation in the cls2 mutant (Figure 9).
Discussion
C a r d i o l i p i ni sk n o w nt op l a yar o l ei nt h ea d a p t i v e
mechanisms of some bacteria to high salinity stress
[15,20,37]. For example, a deficiency in CL decreases
the growth rate in B. subtilis under conditions of 1.5 M
(8.76%) NaCl [24]. Additionally, salt-sensitive S. aureus
mutants contain no or only a small amount of CL
[38,39]. Therefore, we were surprised to find that the
growth of S. aureus under conditions of high salinity
did not depend on CL (Figure 6). This may be attributa-
ble to the presence of other mechanisms, including spe-
cies-specific systems such as variations in cell wall
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Page 6 of 12proteins [14], that give staphylococci the ability to cope
with high-salt stress [11,40]. However, this study is, to
our knowledge, the first to demonstrate that CL is
important for long-term fitness of S. aureus under con-
ditions of high salinity. This is an important finding in
understanding the NaCl resistance of S. aureus,w h i c h
is itself important for commensal growth on skin and
mucus membranes, survival on dry surfaces during
indirect transmission, and persistence in foods with a
high salt content [41].
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Page 7 of 12Cardiolipin depletion did not increase the susceptibil-
ity of S. aureus to cell wall-targeted antibiotics, suggest-
ing that CL alone is not responsible for bacterial
survival against these challenges. We also examined the
susceptibility of S. aureus and its cls mutants to cationic
antimicrobial peptides; because cardiolipin is negatively
charged, a decrease in total negative charge on the
membrane surface may contribute to reduced cationic
antimicrobial peptide resistance [42]. However, CL
depletion had no effect on susceptibility to the antimi-
crobial peptides ASABF-a and nisin. It is possible that
the net negative charge is compensated for by other
membrane components such as PG. In fact, the PG
level was increased in the mutants that did not accumu-
late CL. The importance of positively charged lysyl-
phosphatidylglycerol (LPG) (or MprF protein) in resis-
tance to cationic antimicrobial peptides has been
reported [43,44], and the LPG level was not different
between wild-type S. aureus and cls mutants. In addi-
tion to the probable effect of cell surface charge, we
have previously reported that cell wall thickness is an
important factor affecting resistance to the antimicrobial
peptide ASABF-a [33]. Furthermore, in the present
study, ASABF-a-resistant strains had cell walls that
interfered with CL extraction (Additional file 1, Figure
S1). Cell wall thickness may also be related to resistance
against other antimicrobial peptides in S. aureus [45,46].
Our data indicate that lysostaphin treatment is critical
for the efficient extraction of CL from S. aureus.P r e -
vious reports have suggested that CL is not readily
extractable from B. subtilis and other Gram-positive
bacteria without lysozyme treatment [47]. This may be
attributable to its large molecular mass (~1500 Da) rela-
tive to that of other phospholipids, owing to its four
acyl residues. However, ~25-kDa globular hydrophilic
molecules can pass freely through the ~2-nm holes in
the peptidoglycan polymer that forms the cell wall of
Gram-positive bacteria [48]. Instead, the efficiency of CL
extraction is likely reduced by its physical interactions
with cell wall components; for example, when CL is
bound to cell wall components, it will not efficiently
enter the organic phase during extraction.
T h em e m b r a n eo ft h eL - f o r mv a r i a n t so fS. aureus is
thought to express certain features that support cell
growth and survival in the absence of a rigid cell wall.
One study reported that a particular L-form strain had
an increased CL level [36]. Our data demonstrate that
the cls2 gene is important for normal L-form generation.
However, the cls1/cls2 double mutant still produced
L-form cells, suggesting the existence of a CL-independent
mechanism. Thus, multiple mechanisms may function in
cooperation to generate L-form variants. The production
of a number of factors such as carotenoids, catalase, coa-
gulase, lipase, fibrinolysin, hemolysin, and enterotoxin
changes upon L-form generation and reversion [49-52].
However, none of these represents a common L-form var-
iant phenotype, suggesting that L-form generation is asso-
ciated with a drastic phenotypic conversion. The increase
in CL content may be important, but not essential, for
membrane stabilization.
In this study, both cls1 and cls2 were shown to encode
functional CL synthases. Under our experimental condi-
tions, cls2 was the dominant CL synthase gene. The cls1
mutant did not differ from the parental strain in its
growth rate, survival at stationary phase, total CL accu-
mulation, or L-form generation. However, our data indi-
cate that the synthesis of CL by Cls1 helps the cls2
mutant to survive prolonged incubation under high-salt
conditions (Figure 5E), suggesting that Cls1 has a speci-
fic function under stress conditions if Cls2 is unavail-
able. Future studies should examine the functional
characteristics of these two CL synthases, including pos-
sible differences in their subcellular localizations.
Conclusions
Improved lipid extraction and molecular genetic ana-
lyses showed that both cls1 and cls2 participate in CL
accumulation. The cls2 gene appears to serve a house-
keeping function, while cls1 is active under stress condi-
tions. Staphylococcus aureus can grow under conditions
of high salinity without CL, but CL is required to sur-
vive prolonged high salinity stress and to generate L-
form variants. This CL-dependent survival helps to
explain the success of S. aureus as a human pathogen
and skin/mucus membrane commensal.
Methods
Bacterial strains and culture conditions
The S. aureus strains used in this study are shown in
Table 1. Luria-Bertani (LB) broth was the basic culture
medium, and its NaCl content was modified as indi-
cated. Cells were pre-cultured aerobically at 37°C over-
night with shaking (180 rpm; BR-15; TAITEC, Tokyo,
Japan). Culture inoculate (200 μl) was added to 40 ml of
LB containing 0.1% NaCl or 15% NaCl in a 200 ml
Erlenmeyer flask and incubated at 37°C with shaking
(230 rpm; BR-23UM; TAITEC). To achieve the 25%
NaCl culture condition, 0.4 ml of an overnight culture
was mixed with 2 ml of LB containing 30% NaCl, and
the culture was incubated at 37°C with shaking
(180 rpm; BR-15; TAITEC). When necessary, the pH
was adjusted to 7.0 or 4.8, and the cells were harvested
at exponential phase before any change in pH. The
growth rate was measured spectrophotometrically as
optical density at 600 nm (OD600). Anaerobic growth
was carried out at 37°C without shaking. Mutant isola-
tion procedures used tryptic soy broth (TSB) or brain
heart infusion (BHI) medium.
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Cells equivalent to 8 × 10
8 CFU were collected at expo-
nential or stationary phase, washed in 2% NaCl, and
resuspended in 200 μl of 2% NaCl. Lysostaphin (0.1 mg
ml
-1) was added, and the mixture was incubated at 37°C
for 3 min. The lysed cell suspension was extracted with
chloroform-methanol. Briefly, a five-fold volume of
chloroform-methanol (2:1; v/v) was added, mixed vigor-
ously for 2 min, and left at room temperature for 10 min.
Following the addition of a three-fold volume of chloro-
form-2% NaCl (1:1; v/v) and centrifugation, the lower
layer was recovered and concentrated under vacuum.
The lipids were dissolved in chloroform-methanol (2:1;
v/v), applied to silica thin-layer chromatography (TLC)
Table 1 Bacterial strains, plasmids, and primers used in this study
Strain or plasmid Relevant characteristics Source/reference
S. aureus strain
RN4220 8325-4 derivative that accept foreign DNA [55]
R cls1 RN4220 ΔSA1155;C m
r This study
R cls2 RN4220 ΔSA1891; Tet
r This study
R cls1/cls2 RN4220 ΔSA1155/ΔSA1891;C m
r Tet
r This study
N315 pre-methicillin resistant strain [56]
N cls1 N315 ΔSA1155;C m
r This study
N cls2 N315 ΔSA1891; Tet
r This study
N cls1/cls2 N315 ΔSA1155/ΔSA1891;C m
r Tet
r This study
8325-4 NCTC 8325 cured of prophages, rsbU(-) [57]
8 cls1 8325-4 ΔSA1155;C m
r This study
8 cls2 8325-4 ΔSA1891; Tet
r This study
8 cls1/cls2 8325-4 ΔSA1155/ΔSA1891;C m
r Tet
r This study
SH1000 8325-4 derivative, rsbU repaired, rsbU(+) [58]
S cls1 SH1000 ΔSA1155;C m
r This study
S cls2 SH1000 ΔSA1891; Tet
r This study
S cls1/cls2 SH1000 ΔSA1155/ΔSA1891;C m
r Tet
r This study
MT01 isolate from healthy host, able to generate L-form This study
MT01 cls1 MT01 ΔSA1155;C m
r This study
MT01 cls2 MT01 ΔSA1891; Tet
r This study
MT01 cls1/cls2 MT01 ΔSA1155/ΔSA1891;C m
r Tet
r This study
plasmids
pMAD thermosensitive, pE194
ts-based delivery vector [53]
pMADcat1155 pMAD-based SA1155 targeting vector This study
pMADtet1891 pMAD-based SA1891 targeting vector This study
pHY300PLK shuttle vector, tet (Tet
R) Takara, Japan
pRIT5H shuttle vector, cm(Cm
R) [54]
primers 5’-3’
Tet-F(Sal) CATATTGTCGACTAAGTGATGAAATACTG
Tet-R(EcoRI) GGAATTCCTGTTATAAAAAAAGGATCAAT
CAT(Sal)F CGAGTCGACGATAAAGTGGGATATTTT
CAT(Eco)R CGAATTCCGGGGCAGGTTAGTGACATT
clsU1p TGGATCCTGATATTGCTTACATACT
clsU2p TGGGTCGACAAAAAGTACAAATAGC
clsD1p CACAGATCTTATGGACTTTAGAAGTT
clsD2p TTTAGATCTCAATATCATCCAAATTA
1891U1 CGGATCCAATAGTCCGACGATAGCT
1891U2 GAAGTCGACGTCCTAATAGTAAGTA
1891D1 TGAATTCACAAAAGCACGTTATGCT
1891D2 TGAAGATCTAACATCACAACGGCATA
Cm: chloramphenicol, Tet: tetracycline.
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developed with chloroform-methanol-acetic acid
(65:25:10; v/v/v). The TLC plates were sprayed with
CuSO4 (100 mg ml
-1) containing 8% phosphoric acid and
heated at 180°C to visualize the phospholipids. A digital
image was obtained using a scanner, and signal intensi-
ties were quantified by ImageJ software (version 1.43U,
NIH).
Construction of mutants
To construct S. aureus mutants, we used pMAD, which
is designed for efficient allelic replacement in Gram-
positive bacteria [53], and incorporated the tetracycline
or chloramphenicol resistance gene to make it suitable
for use with erythromycin-resistant hosts such as S. aur-
eus N315. The tet gene was amplified with primers Tet-
F(Sal) and Tet-R(EcoRI) using pHY300PLK (Takara
Shuzo Co. Ltd., Kyoto, Japan) as a template and ligated
into the EcoRI-SalI site of pMAD to generate pMADtet.
The cat gene was amplified from pRIT5H [54] with pri-
mers CAT(Sal)F and CAT(Eco)R and ligated into the
EcoRI-SalI site of pMAD to generate pMADcat.
Target vectors were designed to replace the SA1155
(cls1)a n dSA1891 (cls2) genes with cat and tet, respec-
tively. Two regions encompassing SA1155 were ampli-
fied with the primer pairs clsU1p and clsU2p (upstream
region) and clsD1p and clsD2p (downstream region),
restricted at the primer-attached sites, and sequentially
ligated into the BamHI-SalIa n dBglII sites of pMADcat
to generate the target plasmid pMADcat1155. Similarly,
the upstream and downstream regions of SA1891 were
amplified with the primer pairs 1891U1 and 1891U2,
and 1891D1 and 1891D2, and then sequentially ligated
into the BamHI-SalIa n dEcoRI-BglII sites of pMADtet
to generate pMADtet1891. These target vectors were
introduced into S. aureus RN4220 and N315 by electro-
poration. Each mutant was isolated as described pre-
viously [53]. Briefly, b-galactosidase-positive colonies
carrying the target vector were plated on TSB agar
(TSA) containing antibiotic (12.5 μgm l
-1 Cm or 5 μg
ml
-1 Tet) and 100 μgm l
-1 X-gal, followed by incubation
at 42°C overnight. Several resulting blue colonies were
pooled and subjected to three cycles of growth in drug-
free TSB at 30°C for 12 h and at 42°C for 12 h. Dilu-
tions were plated on drug-free TSA plates containing
100 μgm l
-1 X-gal. Homologous recombination in white
colonies was detected by PCR and Southern blot ana-
lyses. The SA1155/SA1891 double mutants of RN4220
and N315, the SA1155 and SA1891 single mutants, and
the SA1155/SA1891 double mutants of SH1000, 8325-4,
and MT01 were obtained by phage transduction. The
absence of the genes in each mutant was confirmed by
Southern blot analysis and/or PCR.
Antibiotic and antimicrobial peptide susceptibility test
Cells were grown overnight in 5 ml of drug-free Muller-
Hinton (MH) broth at 37°C with shaking (180 rpm; BR-1;
TAITEC). These cells were diluted with MH (×10
-4)a n d
plated onto MH agar. Antibiotic susceptibilities of the
strains were compared using the disk diffusion method
(BD BBL sensi-Disk; Becton, Dickinson and Co., Franklin
Lakes, NJ). The susceptibilities to ASABF-a were mea-
sured as described previously [33]. The minimum inhibi-
tory concentration (MIC) of nisin (from Lactococcus lactis;
Sigma, St. Louis, MO) was determined by microdilution
with 10
4 cells per well and a 20-h incubation at 37°C.
L-form induction
Cells were cultured in BHI without antibiotics, and 100 μl
of the overnight culture were spread onto BHI agar plates
containing 5% NaCl, 5% sucrose, 10% heat-inactivated
horse serum, and 100 μgm l
-1 penicillin. The presence of
serum selects for the stable L-form of S. aureus [34]. The
plates were incubated at 37°C, and colonies showing the
L-form (’fried egg shape’) were counted for 8 days post-
inoculation [34].
Additional material
Additional file: Figure S1 - The phospholipid analysis of ASABF-a-
susceptible strains and resistant strains. Strains N315, NKSB, NKSBv,
and MRSA no. 33 are susceptible to ASABF-a, and strains NKSBm, MRSA
no. 7, and Mu50 are resistant [33]. Cells were harvested at stationary
phase. Lipids were extracted by the chloroform-methanol method
without (A) or with (B) the lysostaphin treatment. Solvent system:
chloroform-methanol-acetic acid (65:25:10; v/v/v). Mu50 has unusually
thick cell walls (ref*) and required higher lysostaphin concentration for
efficient CL extraction (data not shown). ref*: Cui, L., X. Ma, K. Sato, K.
Okuma, F. C. Tenover, E. M. Mamizuka, C. G. Gemmell, M. N. Kim, M. C.
Ploy, N. El-Solh, V. Ferraz, and K. Hiramatsu. 2003. Cell wall thickening is a
common feature of vancomycin resistance in Staphylococcus aureus.
J Clin Microbiol 41:5-14.
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